5,6-Dimethyl-n-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine

Catalog No.: 
ACKMSW814
CAS No.: 
941869-99-4
Molecular Formula: 
C15H15N3S
Molecular Weight: 
269.37
5,6-Dimethyl-n-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00InquiryInquiry
1g95%$350.00InquiryInquiry
5g95%$1020.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,6-Dimethyl-n-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine
IUPAC Name5,6-dimethyl-N-(pyridin-3-ylmethyl)benzo[d]thiazol-2-amine
Molecular FormulaC15H15N3S
Molecular Weight269.37
SMILESCC1=C(C)C=C2N=C(NCC3=CC=CN=C3)SC2=C1
InChI KeyYHUMVIIRTINZFO-UHFFFAOYSA-N
Synonym5,6-dimethyl-N-(pyridin-3-ylmethyl)-1,3-benzothiazol-2-amine;5,6-dimethyl-N-((pyridin-3-yl)methyl)benzo[d]thiazol-2-amine;2-Benzothiazolamine, 5,6-dimethyl-N-(3-pyridinylmethyl)-
CAS No.941869-99-4

Synthetic Route by SureRoute

1. ACKMSW814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWHRZ126 route compound structure diagram
    ACWHRZ12629927-08-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKMSW814 route product structure diagram
    ACKMSW814941869-99-4
Inquiry

2. ACKMSW814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWHRZ126 route compound structure diagram
    ACWHRZ12629927-08-0In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKMSW814 route product structure diagram
    ACKMSW814941869-99-4
Inquiry

3. ACKMSW814 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWHRZ126 route compound structure diagram
    ACWHRZ12629927-08-0In Stock
  4. Then
  5. ACKMSW814 route product structure diagram
    ACKMSW814941869-99-4
Inquiry

Comments (0)